Patent US5147354B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US4900673A Expired / Lapsed US ⏱️ 0.0 years remaining

Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression

Assignee: Harvard University
•
Filing: 1988-03-28
•
Granted: 1990-02-13
•
Expires: 2008-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Site-specific mutagenesis of a gene for angiogenin producing DNA sequences encoding mutant proteins having increased angiogenic activity are disclosed. Expression vectors containing these sequences are introduced into host cells and direct the production of the mutant angiogenic proteins with markedly increased angiogenic and ribonucleolytic activity. Replacement of a single amino acid, the aspartic acid at or corresponding to position 116 of angiogenin, with another amino acid including asparagine, alanine or histidine, yields mutant proteins with 8 to 15 fold increased ribonucleolytic activity toward tRNA and rRNA and 10 to 100 fold increased angiogenic potency in the chorioallantoic membrane assay. The mutant angiogenin proteins of this invention are useful therapeutic compositions to promote the development of a hemovascular network in a mammal or to promote wound healing, in particular, healing of torn or traumatized fibrocartilage material.

Inventors

  • 👤 Jeffrey W. Harper
  • 👤 Bert L. Vallee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:59
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/515; A; A61; A61P; A61P17/00; A61P43/00; A61P9/00; A61P9/14; A61K; A61K38/00

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 33 words
A mutant angiogenin protein wherein the aspartic acid at position 116 as shown in FIG. 5 has been replaced with another amino acid, the mutant angiogenin protein having increased angiogenic and ribonucleolytic activity.
Claim 2
Dependent Claim 33 words
A mutant angiogenin protein wherein the aspartic acid at position 116 as shown in FIG. 5 has been replaced with another amino acid, the mutant angiogenin protein having increased angiogenic and ribonucleolytic activity.
Claim 3
Dependent Claim 24 words
A mutant angiogenin protein according to claim 1 wherein the amino acid replacing the aspartic acid at position 116 with asparagine, alanine or histidine.
Claim 4
Dependent Claim 16 words
An isolated DNA sequence comprising a coding sequence for the mutant angiogenin protein of claim 1.
Claim 5
Dependent Claim 16 words
An isolated DNA sequence comprising a coding sequence for the mutant angiogenin protein of claim 2.
Claim 6
Dependent Claim 16 words
A vector capable of transforming a bacterial host cell comprising the DNA sequence of claim 3.
Claim 7
Dependent Claim 23 words
A vector according to claim 5 further comprising a tryptophan promoter and a translation initiation region sequence operably linked to said DNA sequence.
Claim 8
Dependent Claim 16 words
A vector capable of transforming a bacterial host cell comprising the DNA sequence of claim 4.
Claim 9
Dependent Claim 23 words
A vector according to claim 7 further comprising a tryptophan promoter and a translation initiation region sequence operably linked to said DNA sequence.
Claim 10
Dependent Claim 20 words
A host cell transformed or transfected to contain and express a DNA sequence coding for the protein of claim 1.

References Cited (Backward Citations)

US4721672A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-02-12 1993-08-14 1994-02-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-02-12 1997-08-14 1998-02-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-02-12 2001-08-14 2002-02-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag